Mirae Asset Global ETFs Holdings
KALV

Mirae Asset Global ETFs Holdings’s KalVista Pharmaceuticals KALV Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio KALV Stock Details KALV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$436K Buy
22,005
+381
+2% +$6.14K ﹤0.01% 1952
2025
Q4 		$347K Buy
21,624
+1,112
+5% +$14.7K ﹤0.01% 2078
2025
Q3 		$250K Sell
20,512
-2,452
-11% -$33.9K ﹤0.01% 2208
2025
Q2 		$260K Sell
22,964
-1,361
-6% -$16.6K ﹤0.01% 2153
2025
Q1 		$281K Buy
24,325
+2,939
+14% +$30K ﹤0.01% 2139
2024
Q4 		$181K Sell
21,386
-1,204
-5% -$12.5K ﹤0.01% 2435
2024
Q3 		$263K Buy
22,590
+6,320
+39% +$79.5K ﹤0.01% 2228
2024
Q2 		$192K Buy
+16,270
New +$190K ﹤0.01% 2273

Other funds holding KALV

VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's KALV Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its KalVista Pharmaceuticals (KALV) stake by 1.8% in Q1 2026, buying an estimated $6.14K and bringing the position to 22,005 shares worth $436K. The position accounts for ﹤0.01% of the portfolio, ranked #1952.

Mirae Asset Global ETFs Holdings first reported a position in KALV in Q2 2024 and has held it in 8 quarters since. 183 funds tracked by Wall St. Rank hold KALV as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 22,005 shares of KalVista Pharmaceuticals worth $436K as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 381 KalVista Pharmaceuticals shares in Q1 2026, an estimated $6.14K.
  • KalVista Pharmaceuticals made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #1952 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in KalVista Pharmaceuticals in Q2 2024 and has held it in 8 quarters since.
  • 183 funds tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.